Levodopa/Carbidopa/Entacapone Teva

Levodopa, Carbidopa, Entacapone, the active ingredients in Levodopa/Carbidopa/Entacapone Teva, are anti‑Parkinson agents presented as an oral tablet for oral use. They are indicated for the treatment of Parkinson's disease and for managing motor fluctuations in adult patients.

GNH USA supplies Levodopa/Carbidopa/Entacapone Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable global distribution. All batches are manufactured under GMP conditions and are exported to multiple markets.

Levodopa/Carbidopa/Entacapone is used in the Parkinson's disease therapeutic pathway to improve dopaminergic neurotransmission.

- Parkinson's disease: improves motor symptoms by increasing central dopamine levels. - Parkinson's disease motor fluctuations: reduces OFF time and smooths response to levodopa therapy. - Parkinsonian tremor: helps control tremor as part of overall symptom management.

Levodopa/Carbidopa/Entacapone may cause a range of adverse reactions, which are grouped by frequency.

Common Side Effects: - Nausea - Dizziness - Headache - Insomnia - Orthostatic hypotension - Constipation

Serious or Rare Side Effects: - Dyskinesia - Hallucinations - Severe hypotension - Neuroleptic malignant syndrome - Severe depression - Cardiac arrhythmias

When prescribing Levodopa/Carbidopa/Entacapone, clinicians should consider several safety measures.

- Dose titration: adjust the dose gradually under medical supervision. - Cardiovascular monitoring: watch for orthostatic hypotension and arrhythmias. - Psychiatric assessment: monitor for hallucinations, confusion, or mood changes. - Renal/hepatic function: evaluate organ function and adjust dosing if impairment is present. - Drug interactions: review all concomitant medications for potential interactions. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Levodopa/Carbidopa/Entacapone can interact with other medicines; awareness of the interaction level guides clinical decisions.

Major Interactions (Avoid): - Non‑selective MAO inhibitors: risk of hypertensive crisis. - Anticholinergic drugs: may exacerbate confusion or cognitive impairment. - High‑dose pyridoxine (vitamin B6): reduces levodopa efficacy.

Moderate Interactions (Monitor Closely): - Antidepressants (SSRIs, SNRIs): may increase risk of serotonin syndrome. - Antihypertensives: additive blood‑pressure‑lowering effect. - Iron or calcium supplements: decrease levodopa absorption when taken concurrently.